NPAT, according to the CEO, answering a shareholder question on the Half Year results call, the R&D Expenditure going forward will be focused on what customers want rather than spend/develop and hope customers take up the new offering.
In fact the CEO said that going forward some R&D is co-funded by the client. So it seems this is the new permanent approach to R&D expenditure and therefore IRI should see a step change down in the spend and as a consequence a corresponding increase in NPAT.
Cheers…..D
NPAT, according to the CEO, answering a shareholder question on...
Add IRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
-0.015(2.24%) |
Mkt cap ! $116.1M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 69.0¢ | 64.5¢ | $259.0K | 390.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43814 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 3969 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| IRI (ASX) Chart |